Approaches to treatment-resistant bipolar affectively ill patients.
D000927:Anticonvulsants / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004351:Drug Resistance; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D016651:Lithium Carbonate
D000927:Anticonvulsants; D002121:Calcium Channel Blockers; D016651:Lithium Carbonate; D008094:Lithium